Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : International Nursing Services Inc, old (NURS) new (MDIX) -- Ignore unavailable to you. Want to Upgrade?

To: Mike Moran who wrote (975)	5/7/1998 12:32:00 AM
From: Doug Fir	Read Replies (1) \| Respond to of 2911

I am unsure of the tenor of your posting: <Frankly, as a 23 year health care professional, the announcement of the working Loyola installation, given the past resources of Cymedix, is nothing short of miraculous. The questions raised should have been, what can Cymedix do if they had the resources to install and support their product? Or, Loyola marks the beginning of a new era, where secure, inexpensive medical information can be produced and transmitted over the Internet. Does this harbor a revolution in the medical industry? Instead, people posted ... how much cash is the Loyola contract going to generate.Inquiring minds want to know... How much cash is a doctor going to generate? I wonder if it's possible for a company to give up on its shareholders? > I invested in NURS back when it was 1/4. If I didn't have confidence in the company, I would have cashed out long ago. Clearly, the stock needs to trade higher for a variety of reasons...we merely disagree on the most effective means. Do you mean to imply that there is a grander element to consider than revenue? If you and I spoke over a couple of beers, I'd tell you how great it was that lives could be saved, and doctors made more productive, and suffering eased. But I assume others get the idea as well, else wouldn't have been here so long. So I choose not to write an essay on health care, and simply try to contribute to the discussion of MDIX as an investment. Yet, if MDIX fails, someone will take it's place. The idea is just too good and the time is too right, but I would like to see Cymedix lead the way. Doug